Related Experiment Video
Updated: Sep 9, 2025
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Development and diagnostic performance of a sensitive multiplex pneumonia pathogen identification assay for emergency
Pei-Yi Tsui1,2, Chia-Wei Hong3, Yi-Da Tsai3
1Graduate Institute of Medical Sciences, National Defense Medical University, Taipei, Taiwan, Republic of China.
Abstract:
Pneumonia imposes a significant global health burden, with high morbidity and mortality, and challenges in pathogen identification due to diverse etiologies. Conventional culture-based methods are time-consuming and insufficient for fastidious organisms, necessitating advanced diagnostic tools for rapid and accurate pathogen identification, especially in emergency department (ED) settings. To address this, we developed the pneumonia pathogen identification (PPID) assay, a multiplex diagnostic platform based on the single-stranded multiplex PCR amplicons with suspension bead array technology. The PPID assay detects 27 bacterial and viral pathogens within 6 hours. Analytical validation using nucleic acids from reference strains or synthetic oligonucleotides demonstrated high specificity and sensitivity (5-500 copies per reaction). In 135 ED cases with pneumonia, the PPID assay significantly outperformed microbiological culture methods (77.8% vs 45.2%), increasing the overall detection rate to 85.9% when combined. It effectively identified polymicrobial infections in 48.6% of positive cases, including bacterial-viral co-infections, with Klebsiella pneumoniae being the most frequently identified pathogen overall and in mixed infections. These results highlight the PPID assay's rapid and comprehensive diagnostic capability, facilitating early and targeted treatment, particularly in acute care settings. This innovative approach addresses critical unmet clinical needs and improves patient outcomes.IMPORTANCEThe pneumonia pathogen identification assay is a high-throughput multiplex molecular test that detects 27 respiratory pathogens within 6 hours for up to 96 samples. It exhibits high specificity and sensitivity and enhances detection of fastidious pathogens and co-infections, addressing critical diagnostic challenges in emergency settings.
Insights
A new pneumonia pathogen identification (PPID) assay rapidly detects 27 pathogens within 6 hours. This molecular test significantly improves pathogen detection rates in emergency settings compared to traditional methods.
Area of Science:
- Molecular diagnostics
- Infectious disease epidemiology
- Clinical microbiology
Background:
- Pneumonia presents a major global health challenge with high mortality rates.
- Current diagnostic methods, like culture, are slow and often fail to identify all causative pathogens.
- Rapid and accurate pathogen identification is crucial for effective treatment, especially in emergency departments.
Purpose of the Study:
- To develop and validate a novel multiplex diagnostic assay for rapid identification of pneumonia pathogens.
- To evaluate the performance of the pneumonia pathogen identification (PPID) assay in emergency department settings.
- To compare the PPID assay's efficacy against conventional microbiological culture methods.
Main Methods:
- Development of a multiplex PCR-based diagnostic platform using suspension bead array technology.
- Detection of 27 bacterial and viral pathogens within a 6-hour timeframe.
- Analytical validation with reference strains and synthetic oligonucleotides, followed by clinical evaluation in 135 emergency department pneumonia cases.
Main Results:
- The PPID assay demonstrated high specificity and sensitivity (5-500 copies/reaction).
- In clinical evaluation, the PPID assay identified pathogens in 77.8% of cases, significantly outperforming culture (45.2%).
- The combined detection rate reached 85.9%, with 48.6% of positive cases showing polymicrobial infections, including bacterial-viral co-infections.
Conclusions:
- The PPID assay offers a rapid, comprehensive, and sensitive diagnostic solution for pneumonia pathogens.
- This molecular assay significantly enhances pathogen detection in emergency settings, improving upon traditional culture methods.
- Early and targeted treatment facilitated by the PPID assay can lead to improved patient outcomes in acute care.
